The authors thank Dr. Lynda Partridge for the provision of advice and laboratory facilities.

1) Получение клеточной линии: <ol><li> Разработка RBL-2H3.1 клеточную линию, выражающую лошадей FcεRI α: <ol><li> Использование основных методов культуры ткани для линий монослоя клеток, трансфекции родительских RBL-2H3.1 клеток с использованием плазмиды рЕЕ6, неся лошадиный ген FcεRIα (GenBank: Y18204.1) 28. Добавить мкл 2 мкг -1 плазмидной ДНК в 0,8 мл клеток при плотности 1,2 x10 7 клеток мл -1. Электропорации клетки при 250 В 960 мкФ с использованием 0,4 см electrocuvette затем сразу инкубировать на льду в течение 10 мин. </li><li> Выберите трансформированных клеток с использованием средств массовой информации, содержащие 0,4 г сульфата генетицина G418, затем отсортировать оставшиеся живые клетки через FACS, помечая их флуоресцентным IgE антитела. Используйте полученную RBL-2H3.1 выражающее лошадей клеточной линии FcεRIα для расследования 2, 3. </li></ol></li><li> Предварительная проба антитела сенсибилизация: <ol><lя&gt; Урожай RBL-2H3.1 выражения лошадей FcεRIα клетки от сливной чашки Петри. Промыть затем повторно суспендирования клеток в культуральной среде до плотности клеток -1 5x10 5 клеток мл. </li><li> Добавьте IgE интерес взвешенных клеток в конечной концентрации 1 нг мл -1, то пластина 100 мкл клеток на 96-луночный планшет в столбцах 1-6, и инкубируют при температуре 37 ° С ± 5% CO 2 + 90% относительной влажности в течение 16 ч. После инкубационного периода, и перед выполнением анализа высвобождения, проверить колодцы под микроскопом для а слияния и клеточной приверженности. </li></ol></li></ol> 2) Анализ выпуска: <ol><li> Стиральная клетки: <ol><li> Буфер Теплый выпуск (25 мм труб, 120 мМ хлорида натрия, 5 мМ хлорида калия, 0,04 мМ хлорида магния и 1 мМ хлорида кальция) при 37 ° С, чтобы обеспечить осторожного промывания клеток. </li><li> Вымойте клеток, щелкая пластину, чтобы удалить клеточную среду и добавлением 100 мкл теплой, 37 ° C, релиз буфер. Повторите два раза. </li></ol></li><li> Антигена: <ol><li> Приготовьте серийное разведение антигена (NIP-HSA или DNP-HSA) в 0 нг мл -1, 0,1 нг мл -1, 1 нг мл -1, 10 нг мл -1, 100 нг мл -1, 1000 нг мл -1, 10000 нг мл -1 в буфере выпуска и тепло при 37 ° С. </li><li> После второй промывки клеток, отбросить носитель и заменяют 100 мкл антигена решений. Убедитесь, что скважины в той же строке (A1-6 например) имеют одинаковую концентрацию антигена добавленную к ним. </li><li> Настройка негативного контроля в строке А, добавив 0 нг мл -1 антиген. Добавить возрастающую концентрацию антигена вниз по строкам (BG) с последующим Triton-X-буфера (5% Тритон Х-100) в строки H клеток, чтобы лизировать клетки, которые будут использоваться в качестве положительного контроля. Инкубируют при 37 ° С в течение 20 мин, чтобы позволить клетки, чтобы освободить ее медиаторы. </li></ol></li><li> Настройка отдельных элементов управления также: <ol><li> После инкубации передачи 50 мкл клеточного супернатанта к другой половине пластины (A1-6 скважин в скважинах A7-12 и т.д.). Отменить оставшиеся 50 мкл супернатанта и заменить с 50 мкл тритона-X буфера, чтобы позволить измерение количества выпущенных медиаторов в каждую лунку в колонках 7-12, как процент от общего объема медиаторов внутри клеток в колонке 1-6 , </li></ol></li><li> Фермент субстрата: </li><li> Добавить 50 мкл β-гексозаминидазы субстрата (50 мМ 4-нитрофенил N-ацетил-β-D-глюкозаминида подготовлен в ДМСО разбавляли до 2 мМ, добавляя его в цитратном буфере 0,2 М лимонной кислоты и 0,2 М ацетата натрия, рН 4,5) во все лунки, чтобы способствовало превращение субстрата в 4-нитрофенола в β-гексозаминидазы фермента. Инкубируйте пластин при 37 ° С в течение 2 часов. </li></ol><img alt="Рисунок 2.4.1" fo:content-width="4in" src="/files/ftp_upload/52222/52222fig241.jpg" widtч = &quot;400&quot; /&gt; <ol start="5"><li> Завершение реакции: <ol><li> Остановить реакцию, добавив в 150 мкл трис-буфера (1 М Трис-HCl, рН 9) в каждую лунку в качестве высоких рН буфера останавливает реакцию и превращает 4-нитрофенол в желтый цвет. </li></ol></li><li> Чтение и анализ результатов: <ol><li> Read пластину с использованием планшет-спектрофотометре при длине волны 405 нм для измерения оптической плотности желтого цвета. Расчетное процентное содержание β-опубликованном гексозаминидазы, используя следующую формулу: </li></ol></li></ol><img alt="Рисунок 2.6.1" fo:content-width="1in" src="/files/ftp_upload/52222/52222fig261.jpg" width="100" /><ol start="2"><li> Применить эту формулу в каждую лунку, после чего берется среднее значение для каждой строки. A1 и A7 представляют расположение скважин в 96-луночный планшет. Показать график процент β-гексозаминидазы выпуска (что соответствует общей выпуска медиатора) AgaiНСТ антиген концентрация 2, 3. </li></ol>

<ol>
	<li>Taudou, G., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Expression+of+the+Alpha+Chain+of+Human+Fc&#949;RI+in+Transfected+Rat+Basophilic+Leukemia+Cells:+Functional+Activation+after+Sensitization+with+Human+Mite-Specific+IgE.">Expression of the Alpha Chain of Human Fc&#949;RI in Transfected Rat Basophilic Leukemia Cells: Functional Activation after Sensitization with Human Mite-Specific IgE.</a> Int Arch Allergy Immunol. 100 (4), 344-350 (1993).</li><li>Sabban, S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=.">.</a> Development of an in Vitro Model System for Studying the Interaction of EquuscaballusIgE with Its High-Affinity Fc&#949;RI Receptor. , (2011).</li><li>Sabban, S., Ye, H., Helm, B. A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Development+of+an+in+Vitro+Model+System+for+Studying+the+Interaction+of+EquuscaballusIgE+with+Its+High-Affinity+Receptor+Fc&#949;RI.">Development of an in Vitro Model System for Studying the Interaction of EquuscaballusIgE with Its High-Affinity Receptor Fc&#949;RI.</a> Vet ImmunolImmunopathol. 153 (1-2), 6-10 (2013).</li><li>Wilson, A. P. M., Pullar, C. E., Camp, A. M., Helm, B. A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Human+IgE+mediates+stimulus+secretion+coupling+in+rat+basophilic+leukemia+cells+transfected+with+the+a+chain+of+the+human+high-affinity+receptor.">Human IgE mediates stimulus secretion coupling in rat basophilic leukemia cells transfected with the a chain of the human high-affinity receptor.</a> Eur J Immunol. 23, 240-244 (1993).</li><li>Hunter, M. J., Vratimos, A. P., Housden, J. E. M., Helm, B. A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Generation+of+canine-human+Fc+IgE+chimeric+antibodies+for+the+determination+of+the+canine+IgE+domain+of+interaction+with+Fc&#949;RI&#945;.">Generation of canine-human Fc IgE chimeric antibodies for the determination of the canine IgE domain of interaction with Fc&#949;RI&#945;.</a> MolImmunol. 45 (8), 2262-2268 (2008).</li><li>Rashid, A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Review:+Diagnostic+and+therapeutic+applications+of+rat+basophilic+leukemia+cells.">Review: Diagnostic and therapeutic applications of rat basophilic leukemia cells.</a> MolImmunol. 52 (3-4), 224-228 (2012).</li><li>Cohen, S. G. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Asthma+in+antiquity:+the+Ebers+Papyrus.">Asthma in antiquity: the Ebers Papyrus.</a> Allergy Proc. 13 (3), 147-154 (1992).</li><li>Dudler, T., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=A+link+between+catalytic+activity,+IgE-independent+mast+cell+activation,+and+allergenicity+of+bee+venom+phospholipase+A2.">A link between catalytic activity, IgE-independent mast cell activation, and allergenicity of bee venom phospholipase A2.</a> J. Immunol. 155, 2605-2613 (1995).</li><li>Machado, D. C., Horton, D., Harrop, R., Peachell, P. T., Helm, B. A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Potential+allergens+stimulate+the+release+of+mediators+of+the+allergic+response+from+cells+of+mast+cell+lineage+in+the+absence+of+sensitization+with+antigen-specific+IgE.">Potential allergens stimulate the release of mediators of the allergic response from cells of mast cell lineage in the absence of sensitization with antigen-specific IgE.</a> Eur J Immunol. 26 (12), 2972-2980 (1996).</li><li>Smyth, L. J., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Assessment+of+the+molecular+basis+of+pro-allergenic+effects+of+cigarette+smoke.">Assessment of the molecular basis of pro-allergenic effects of cigarette smoke.</a> Environ Sci Technol. 34 (7), 1370-1374 (2000).</li><li>Okada, H., Kuhn, C., Feillet, H., Bach, J. F. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=The+'hygiene+hypothesis'+for+autoimmune+and+allergic+diseases:+an+update.">The 'hygiene hypothesis' for autoimmune and allergic diseases: an update.</a> ClinExpImmunol. 160 (1), 1-9 (2010).</li><li>Eder, C., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Influence+of+environmental+and+genetic+factors+on+allergen-specific+immunoglobulin-E+levels+in+sera+from+Lipizzan+horses.">Influence of environmental and genetic factors on allergen-specific immunoglobulin-E levels in sera from Lipizzan horses.</a> Equine Vet J. 33 (7), 714-720 (2001).</li><li>Cook, W. R., Rossdale, P. D. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=The+syndrome+of+'Broken+Wind'+in+the+horse.">The syndrome of 'Broken Wind' in the horse.</a> Proceedings of the Royal Society of Medicine. 56, 972-977 (1963).</li><li>Eyre, P., Lewis, A. J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Acute+systemic+anaphylaxis+in+the+horse.">Acute systemic anaphylaxis in the horse.</a> Br. J. Pharmacol. 48 (3), 426-437 (1973).</li><li>Wagner, B. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=IgE+in+horses:+occurrence+in+health+and+disease.">IgE in horses: occurrence in health and disease.</a> Vet ImmunolImmunopathol. 132 (1), 21-23 (2009).</li><li>Hellberg, W., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Equine+insect+bite+hypersensitivity:+immunoblot+analysis+of+IgE+and+IgG+subclass+responses+to+Culicoidesnubeculosus+salivary+gland+extract.">Equine insect bite hypersensitivity: immunoblot analysis of IgE and IgG subclass responses to Culicoidesnubeculosus salivary gland extract.</a> Vet. Immunol. Immunopathol. 113 (1-2), 99-112 (2006).</li><li>Schaffartzik, A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Equine+insect+bite+hypersensitivity:+what+do+we+know.">Equine insect bite hypersensitivity: what do we know.</a> Vet ImmunolImmunopathol. 147 (3-4), 113-126 (2012).</li><li>K&#252;nzle, F., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=IgE-bearing+cells+in+bronchoalveolar+lavage+fluid+and+allergen-specific+IgE+levels+in+sera+from+RAO-affected+horses.">IgE-bearing cells in bronchoalveolar lavage fluid and allergen-specific IgE levels in sera from RAO-affected horses.</a> J Vet Med A PhysiolPatholClin Med. 54 (1), 40-47 (2007).</li><li>Tahon, L., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=In+vitro+allergy+tests+compared+to+intradermal+testing+in+horses+with+recurrent+airway+obstruction.">In vitro allergy tests compared to intradermal testing in horses with recurrent airway obstruction.</a> Vet ImmunolImmunopathol. (1-2), 85-93 (2009).</li><li>Wagner, B., Radbruch, A., Rohwer, J., Leibold, W. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Monoclonal+anti-equine+IgE+antibodies+with+specificity+for+different+epitopes+on+the+immunoglobulin+heavy+chain+of+native+IgE.">Monoclonal anti-equine IgE antibodies with specificity for different epitopes on the immunoglobulin heavy chain of native IgE.</a> Vet ImmunolImmunopathol. 92 (1-2), 45-60 (2003).</li><li>Wilson, A. D., Harwood, L., Torsteinsdottir, S., Marti, E. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Production+of+monoclonal+antibodies+specific+for+native+equine+IgE+and+their+application+to+monitor+total+serum+IgE+responses+in+Icelandic+and+non-Icelandic+horses+with+insect+bite+dermal+hypersensitivity.">Production of monoclonal antibodies specific for native equine IgE and their application to monitor total serum IgE responses in Icelandic and non-Icelandic horses with insect bite dermal hypersensitivity.</a> Vet ImmunolImmunopathol. 112 (3-4), 156-170 (2006).</li><li>McAleese, S. M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Cloning+and+expression+of+the+extra-cellular+part+of+the+alpha+chain+of+the+equine+high-affinity+IgE+receptor+and+its+use+in+the+detection+of+IgE.">Cloning and expression of the extra-cellular part of the alpha chain of the equine high-affinity IgE receptor and its use in the detection of IgE.</a> Vet ImmunolImmunopathol. 110 (1-2), 187-191 (2006).</li><li>Ledin, A., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Generation+of+therapeutic+antibody+responses+against+IgE+in+dogs,+an+animal+species+with+exceptionally+high+plasma+IgE+levels.">Generation of therapeutic antibody responses against IgE in dogs, an animal species with exceptionally high plasma IgE levels.</a> Vaccine. 24 (1), 66-74 (2006).</li><li>Siraganian, R. P., Hook, W. A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Histamine+release+and+assay+methods+for+the+study+of+human+allergy.">Histamine release and assay methods for the study of human allergy.</a> Manual of Clinical Immunology. , (1980).</li><li>Neuberger, M. S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=A+hapten-specific+chimaericIgE+antibody+with+human+physiological+effector+function.">A hapten-specific chimaericIgE antibody with human physiological effector function.</a> Nature. 314 (6008), 268-270 (1985).</li><li>Bingham, B. R., Monk, P. N., Helm, B. A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Defective+Protein+Phosphorylation+and+Ca2++Mobilization+in+a+low+secreting+variant+of+the+rat+basophilic+leukemia+cell+line.">Defective Protein Phosphorylation and Ca2+ Mobilization in a low secreting variant of the rat basophilic leukemia cell line.</a> The Journal of Biological Chemistry. 269 (30), 19300-19306 (1994).</li><li>McAleese, S. M., Halliwell, R. E., Miller, H. R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Cloning+and+sequencing+of+the+horse+and+sheep+high-affinity+IgE+receptor+alpha+chain+cDNA.">Cloning and sequencing of the horse and sheep high-affinity IgE receptor alpha chain cDNA.</a> Immunogenetics. 1 (51), 878-881 (2000).</li><li>Hongtu, Y. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Study+of+the+structure/function+relationship+in+canine+and+human+IgE+as+the+basis+for+the+development+of+rational+therapeutic+intervention+strategies+in+allergic+disease.">Study of the structure/function relationship in canine and human IgE as the basis for the development of rational therapeutic intervention strategies in allergic disease.</a> , (2010).</li><li>Sabban, S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Towards+a+pan-anti-allergy+vaccine.">Towards a pan-anti-allergy vaccine.</a> JIBTVA. 2 (2), 15-27 (2013).</li><li>Moran, G., Burgos, R., Araya, O., Folch, H. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=In+vitro+bioassay+to+detect+reaginic+antibodies+from+the+serum+of+horses+affected+with+recurrent+airway+obstruction.">In vitro bioassay to detect reaginic antibodies from the serum of horses affected with recurrent airway obstruction.</a> Vet Res Commun. 34, 91-99 (2010).</li></ol>

The authors declare that they have no competing financial interests in this paper.

В целом результаты этого исследования показали, что, когда RBL-2H3.1 клетки, экспрессирующие лошадей FcεRIα были осведомлены с лошади IgE и оспорены антигена, они дают пик высвобождения медиаторов из 36,68% ± 4,88% от общего количества медиатора внутри клетки, по сравнению с RBL-2H3.1 родительские клет?...

Аллергия, как известно, на протяжении тысячелетий. Лечение астмы был описан в древнеегипетской медицинского текста, известного как папирусе Эберса (~ 1550 г. до н.э.) и обсудили трав для лечения его 7. Сегодня аллергии классифицируется как ответ гиперчувствительности типа I, где Т хелперов типа 2 (TH 2) рычаг иммунной системы бычков производство иммуноглобулина Е (IgE) антител в ответ на антигены окружающей среды, называемых аллергенами. Эти различные вещества, которые обычно взаимодействуют с клетками иммунной системы и стимулируют синтез и секрецию провоспалительных цитокинов, в том числе интерлейкина-4 и интерлейкина-13 8, 9, как у частицы в сигаретном дыме или дизельное выхлопных частиц, которые усиливают синтез IgE 10. Рост аллергических проявлений в промышленно развитых странах в последние 50 лет было обусловлено сочетанием эффектазагрязнителями окружающей среды и тенденция к более облагороженная окружающей среды, сочетающие переложить иммунный ответ к профилю преобладали по ТН 2 цитокинов, предложенные «гигиеническая гипотеза» 11. Как уже упоминалось выше, люди не единственные млекопитающие, страдающие аллергией. Примечательно лошади и собаки могут также развиваться классические аллергические реакции, а также исследование по 12 показал, что, как и у людей, лошадей аллергия приписывается генетических и экологических факторов. Как следствие, эти животные представляют хорошие модели для изучения взаимосвязи между генетическими и экологическими причинами аллергии, ее развитие от чувствительности к болезни и возможных стратегий вмешательства, как только клинические проявления установили в В 1887 году, Stömmer был первым человеком, чтобы описать сходство между человеком и лошадей астмы 13, эффект гистамина на лошади сердечно-сосудистой системы являетсяочень похож на человека 14. Лошади также краеугольным камнем скачки промышленности, которая стоит нам $ 72 млрд с оборотом ставок по US $ 115 млрд в год 15. Большинство современных спортивных лошадей являются потомками небольшого числа арабских лошадей разводят леди Энн Блант с 1878 года. Современные скаковых лошадей, как правило, инбредных выбрать для способностей производительности. Они склонны к генетических расстройств, одним из которых является их чувствительность к монтировать аллергические реакции. Они также имеют в 1000 раз выше сывороточных уровней IgE, чем даже наиболее сильно аллергия человека 16. Верховая аллергические реакции, как правило, проявляется в виде укуса насекомого гиперчувствительности (IBH) 17, 18. Результаты IBH в дерматита из-за укусов образуют насекомых в роду Culicoides. Другая форма лошадей аллергических заболеваний является рецидивирующие препятствия в дыхательных путях (РАО), это проявляется в легких и дыхательных путях. Она характеризуется хрипы и лабораторииORed дыхание. РАО обычно происходит в ответ на споры плесени, и высокие уровни IgE аллерген-специфическая были зафиксированы в лошадей, страдающих от РАО в одном исследовании 19 хотя новое расследование не подтвердило эту 20. Исследования лошадей аллергии вращалась вокруг попытки мониторинга и нейтрализующих лошадей IgE путем разработки анти-лошадей IgE моноклональных антител (моноклональные антитела,) 21, 22. Кроме того, исследование, проведенное 23 обсуждает производство внеклеточных доменов α лошадиный высоким сродством Fc рецептора цепь (FcεRIα) рецепторов в попытке обнаружить и количественного определения в сыворотке IgE лошадей. Связанный с этим исследование Ledin 24 обсуждает новый подход, направленный на нейтрализацию сыворотке IgE путем заливки иммунную систему с помощью собственной / НЕСАМОУПРАВЛЯЮЩИХСЯ иммуногена. Все эти исследования, однако, отсутствует эффективная анализа для проверки безопасности и эффективности их протоколов. В этой статье, мы теперь представляем Такой анализ SYSма применимо к изучению диагностических и терапевтических стратегий, имеющих отношение к лошади системы, где β-гексозаминидазы релиз, в качестве индикатора клеток медиаторов дегрануляции, они были начислены на RBL-2H3.1 клеток, экспрессирующих лошадей FcεRIα. Этот протокол основан на предыдущих публикаций 25, 4, 5, 2, 3, описывающих инженерии RBL клеток, трансфецированных геном, кодирующим связывающий домен IgE рецептора с высоким сродством к IgE из различных видов. Протокол объясняет, как выполнить анализе высвобождения β-гексозаминидазы, результаты которого представлены как среднее ± стандартное отклонение для трех экспериментов. Релиз анализ был впервые разработан Siraganian и Хук 25 для изучения аллергии человека. Лаборатория группа во главе с доктором Рувим Siraganian также разработал RBL клеточной линии. Эти RBL клетки были разработаны, чтобы выразить человеческую FcεRIα и протокол был опубликован 4. Заключительная частьиз анализа пришли с развитием плазмиды ПСВ в работе Neuberger 26, который, описанной производство антител IgE путем клонирования свою тяжелую цепь гена вниз по течению от мышиного гена для вариабельной области IgE, который нацелен на гаптен 4-гидрокси-3 нитро-phenacetyl (NP), в результате чего химерное антитело было полностью функциональной. Способность развивать любую IgE таргетинга то же гаптен, в то же время клонирования его рецептор на поверхности RBL клеток привело к стандартизации анализа, что делает его полезным протокол для измерения дегрануляцию базофилов клеток. Анализ имеет плюсы и минусы. Профи из анализа является его адаптивность, которые будут использоваться в любой системе млекопитающих, наша лаборатория, таким образом, использовал его для проверки дегрануляции в человека, собак и лошадей систем, и это достижимо лишь путем синтеза IgE организма и клонирования его рецептор на поверхности клеток RBL. С другой стороны,Недостатки анализа является то, что клетки RBL очень чувствительны к тепловых, механических и рН изменений, что делает их дать изменение уровней дегрануляции в пределах одной и той же тесте. Он, таким образом, настоятельно рекомендуется, что анализы всегда повторяется трижды, а затем берется среднее значение из них. Кроме того, RBL клетки, как правило, смещаются в сторону не-рилизинг фенотипа, если они остаются в культуре ткани в течение длительного времени (&gt; 10 недель) 27, что делает их обслуживание громоздкой. Они также склонны к инфекциям микоплазмой бактерий, которые не видны с помощью оптического микроскопа и не меняют морфологию ячейки, но кардинально изменить их уровни дегрануляции. Таким образом регулярные тесты микоплазмы необходимы.

<table border="0" cellpadding="0" cellspacing="0">
	<tbody>
		<tr>
			<td>RBL-2H3.1 Expressing Equine Fc&#949;RI&#945;</td>
			<td>-</td>
			<td>-</td>
			<td>Produced in the lab</td>
		</tr>
		<tr>
			<td>Equine IgE anti NIP-HSA</td>
			<td>-</td>
			<td>-</td>
			<td>Produced in the lab</td>
		</tr>
		<tr>
			<td>96 Well Plate</td>
			<td>Sigma</td>
			<td>CLS3595</td>
			<td>-</td>
		</tr>
		<tr>
			<td>Multi Channel Pipette</td>
			<td>Anachem</td>
			<td>-</td>
			<td>-</td>
		</tr>
		<tr>
			<td>Incubator</td>
			<td>Galaxy R</td>
			<td>-</td>
			<td>-</td>
		</tr>
		<tr>
			<td>4Hydroxy-5-iodo-3-nitrophenylacetic acid</td>
			<td>Cambridge Research Biochemicals</td>
			<td>N-1070-1</td>
			<td>NIP-OH was conjugated with Human Serum Albumin to make NIP-HSA in the lab</td>
		</tr>
		<tr>
			<td>Dinitrophenyl Conjugated to Human Serum Albumin</td>
			<td>Sigma</td>
			<td>A6661</td>
			<td>Abbreviated DNP-HSA</td>
		</tr>
		<tr>
			<td>Plate Spectrophotometer</td>
			<td>Anthos Labtec HT2</td>
			<td>-</td>
			<td>-</td>
		</tr>
		<tr>
			<td>Pipes</td>
			<td>Sigma</td>
			<td>P1851</td>
			<td>-</td>
		</tr>
		<tr>
			<td>Sodium Chloride</td>
			<td>Sigma</td>
			<td>S7653</td>
			<td>-</td>
		</tr>
		<tr>
			<td>Potassium Chloride</td>
			<td>Sigma</td>
			<td>P9333</td>
			<td>-</td>
		</tr>
		<tr>
			<td>Magnesium Chloride</td>
			<td>Sigma</td>
			<td>M2670</td>
			<td>-</td>
		</tr>
		<tr>
			<td>Calcium Chloride</td>
			<td>Sigma</td>
			<td>C1016</td>
			<td>-</td>
		</tr>
		<tr>
			<td>Triton x100</td>
			<td>Sigma</td>
			<td>X100</td>
			<td>-</td>
		</tr>
		<tr>
			<td>4-nitrophenyl N-acetyl-&#946;-D-glucosaminide</td>
			<td>Sigma</td>
			<td>N9376</td>
			<td>Stock solution called &#946;-hexosaminidase substrate was 50mM prepared in DMSO</td>
		</tr>
		<tr>
			<td>Dimethyl Sulfoxide</td>
			<td>Sigma</td>
			<td>D2650</td>
			<td>-</td>
		</tr>
		<tr>
			<td>Citric Acid</td>
			<td>Sigma</td>
			<td>251275</td>
			<td>-</td>
		</tr>
		<tr>
			<td>Sodium Acetate</td>
			<td>Sigma</td>
			<td>S7670</td>
			<td>-</td>
		</tr>
		<tr>
			<td>Tris</td>
			<td>Sigma</td>
			<td>T5941</td>
			<td>-</td>
		</tr>
	</tbody>
</table>

development of an in vitro model system for studying the interaction of equus caballus ige with its high-affinity receptor fc&#949;ri

The interaction of IgE with its high-affinity Fc receptor (Fc&#949;RI) followed by an antigenic challenge is the principal pathway in IgE mediated allergic reactions. As a consequence of the high affinity binding between IgE and Fc&#949;RI, along with the continuous production of IgE by B cells, allergies usually persist throughout life, with currently no permanent cure available. Horses, especially race horses, which are commonly inbred, are a species of mammals that are very prone to the development of hypersensitivity responses, which can seriously affect their performance. Physiological responses to allergic sensitization in horses mirror that observed in humans and dogs. In this paper we describe the development of an in situ assay system for the quantitative assessment of the release of mediators of the allergic response pertaining to the equine system. To this end, the gene encoding equine Fc&#949;RI&#945; was transfected into and expressed onto the surface of parental Rat Basophil Leukemia (RBL-2H3.1) cells. The gene product of the transfected equine &#945;-chain formed a functional receptor complex with the endogenous rat &#946;- and &#947;-chains 1. The resultant assay system facilitated an assessment of the quantity of mediator secreted from equine Fc&#949;RI&#945; transfected RBL-2H3.1 cells following sensitization with equine IgE and antigenic challenge using &#946;-hexosaminidase release as a readout 2, 3. Mediator release peaked at 36.68% &#177; 4.88% at 100 ng ml-1 of antigen. This assay was modified from previous assays used to study human and canine allergic responses 4, 5. We have also shown that this type of assay system has multiple applications for the development of diagnostic tools and the safety assessment of potential therapeutic intervention strategies in allergic disease 6, 2, 3.

Родительские RBL-2H3.1 клетки и те, трансфицируют с лошадиного гена рецептора FcεRIα были впервые сенсибилизированные мыши с IgE анти DNP-HSA и вызов с антигена DNP-HSA. Мышь IgE связывается с эндогенным рецептором крыс в обеих клеточных линий и, таким образом, действует в качестве контроля для провер?...

Watch this Scientific Journal Video about Development of an in vitro model system for studying the interaction of Equus caballus IgE with its high-affinity receptor FcÎµRI at JoVE.com

Development of an &lt;em&gt;in vitro&lt;/em&gt; model system for studying the interaction of &lt;em&gt;Equus&lt;/em&gt; &lt;em&gt;caballus&lt;/em&gt; IgE with its high-affinity receptor Fc&amp;#949;RI

The current study describes the development and applications of a genetically engineered assay system based on the transfection of rat basophilic leukemia cells with the equine Fc&#949;RI&#945; gene. Transfected cells express a functional receptor where the release of mediators of the allergic response can be activated by IgE and antigen.

Разработка<em&gt; В пробирке</em&gt; Модельной системой для изучения взаимодействия<em&gt; Equus</em&gt;<em&gt; Caballus</em&gt; IgE с рецептором с высоким сродством FcεRI

The interaction of IgE with its high-affinity Fc receptor (Fc&#949;RI) followed by an antigenic challenge is the principal pathway in IgE mediated ...

development-an-vitro-model-system-for-studying-interaction-equus

Research

JoVE Journal

Immunology and Infection

Development of an in vitro model system for studying the interaction of Equus caballus IgE with its high-affinity receptor Fc&#949;RI

12.3K Views.  King Abdulaziz University. The current study describes the development and applications of a genetically engineered assay system based on the transfection of rat basophilic leukemia cells with the equine FcεRIα gene. Transfected cells express a functional receptor where the release of mediators of the allergic response can be activated by IgE and antigen.

Video: Development of an in vitro model system for studying the interaction of Equus caballus IgE with its high-affinity receptor Fc&#949;RI

Development of a Negative Selectable Marker for Entamoeba histolytica

Entamoeba histolytica is the causative agent of amebiasis and infects up to 10% of the world's population. The molecular techniques that have enabled the up- and down-regulation of gene expression rely on the transfection of stably maintained plasmids. While these have increased our understanding of Entamoeba virulence factors, the capacity to integrate exogenous DNA into genome, which would allow reverse genetics experiments, would be a significant advantage in the study of this parasite. The challenges presented by this organism include inability to select for homologous recombination events and difficulty to cure episomal plasmid DNA from transfected trophozoites. The later results in a high background of exogenous DNA, a major problem in the identification of trophozoites in which a bona fide genomic integration event has occurred. We report the development of a negative selection system based upon transgenic expression of a yeast cytosine deaminase and uracil phosphoribosyl transferase chimera (FCU1) and selection with prodrug 5-fluorocytosine (5-FC). The FCU1 enzyme converts non-toxic 5-FC into toxic 5-fluorouracil and 5-fluorouridine-5'-monophosphate. E. histolytica lines expressing FCU1 were found to be 30 fold more sensitive to the prodrug compared to the control strain.

Development of a Negative Selectable Marker for Entamoeba histolytica

We report development of a negative selection system in E. histolytica based upon transgenic expression of a chimeric protein (FCU1) and selection with the prodrug 5-fluorocytosine. The FCU1 protein is a fusion of yeast cytosine deaminase and uracil phosphoribosyltransferase. Expression of FCU1 resulted in increased E. histolytica sensitivity towards 5-fluorocytosine.

Развитие Отрицательные Маркер для выбора Entamoeba histolytica</em

Entamoeba histolytica is the causative agent of amebiasis and infects up to 10% of the world's population. The molecular techniques that have enabled the ...

In vitro Biofilm Formation in an 8-well Chamber Slide

The chronic nature of many diseases is attributed to the formation of bacterial biofilms which are recalcitrant to traditional antibiotic therapy. Biofilms are community-associated bacteria attached to a surface and encased in a matrix. The role of the extracellular matrix is multifaceted, including facilitating nutrient acquisition, and offers significant protection against environmental stresses (e.g. host immune responses). In an effort to acquire a better understanding as to how the bacteria within a biofilm respond to environmental stresses we have used a protocol wherein we visualize bacterial biofilms which have formed in an 8-well chamber slide. The biofilms were stained with the BacLight Live/Dead stain and examined using a confocal microscope to characterize the relative biofilm size, and structure under varying incubation conditions. Z-stack images were collected via confocal microscopy and analyzed by COMSTAT. This protocol can be used to help elucidate the mechanism and kinetics by which biofilms form, as well as identify components that are important to biofilm structure and stability.

In vitro Biofilm Formation in an 8-well Chamber Slide

This article describes the procedure for the formation and visualization of a bacterial biofilm grown within an 8-well chamber slide

В пробирке образование биопленки в 8-и палаты слайдов

The chronic nature of many diseases is attributed to the formation of bacterial biofilms which are recalcitrant to traditional antibiotic therapy. ...

Establishment of an In vitro System to Study Intracellular Behavior of Candida glabrata in Human THP-1 Macrophages

A cell culture model system, if a close mimic of host environmental conditions, can serve as an inexpensive, reproducible and easily manipulatable alternative to animal model systems for the study of a specific step of microbial pathogen infection. A human monocytic cell line THP-1 which, upon phorbol ester treatment, is differentiated into macrophages, has previously been used to study virulence strategies of many intracellular pathogens including Mycobacterium tuberculosis. Here, we discuss a protocol to enact an in vitro cell culture model system using THP-1 macrophages to delineate the interaction of an opportunistic human yeast pathogen Candida glabrata with host phagocytic cells. This model system is simple, fast, amenable to high-throughput mutant screens, and requires no sophisticated equipment. A typical THP-1 macrophage infection experiment takes approximately 24 hr with an additional 24-48 hr to allow recovered intracellular yeast to grow on rich medium for colony forming unit-based viability analysis. Like other in vitro model systems, a possible limitation of this approach is difficulty in extrapolating the results obtained to a highly complex immune cell circuitry existing in the human host. However, despite this, the current protocol is very useful to elucidate the strategies that a fungal pathogen may employ to evade/counteract antimicrobial response and survive, adapt, and proliferate in the nutrient-poor environment of host immune cells.

Establishment of an In vitro System to Study Intracellular Behavior of Candida glabrata in Human THP-1 Macrophages

The current article outlines a protocol to establish an in vitro cell culture model system to study the interaction of a facultative intracellular human fungal pathogen Candida glabrata with human macrophages which will be a useful tool to advance our knowledge of fungal virulence mechanisms.

Создание<em&gt; В пробирке</em&gt; Система по изучению внутриклеточных Поведение<em&gt; Candida glabrata</em&gt; В человека ТНР-1 макрофагов

A cell culture model system, if a close mimic of host environmental conditions, can serve as an inexpensive, reproducible and easily manipulatable ...

A Novel In vitro Model for Studying the Interactions Between Human Whole Blood and Endothelium

The majority of all known diseases are accompanied by disorders of the cardiovascular system. Studies into the complexity of the interacting pathways activated during cardiovascular pathologies are, however, limited by the lack of robust and physiologically relevant methods. In order to model pathological vascular events we have developed an in vitro assay for studying the interaction between endothelium and whole blood. The assay consists of primary human endothelial cells, which are placed in contact with human whole blood. The method utilizes native blood with no or very little anticoagulant, enabling study of delicate interactions between molecular and cellular components present in a blood vessel.
We investigated functionality of the assay by comparing activation of coagulation by different blood volumes incubated with or without human umbilical vein endothelial cells (HUVEC). Whereas a larger blood volume contributed to an increase in the formation of thrombin antithrombin (TAT) complexes, presence of HUVEC resulted in reduced activation of coagulation. Furthermore, we applied image analysis of leukocyte attachment to HUVEC stimulated with tumor necrosis factor (TNF&#945;) and found the presence of CD16+ cells to be significantly higher on TNF&#945; stimulated cells as compared to unstimulated cells after blood contact. In conclusion, the assay may be applied to study vascular pathologies, where interactions between the endothelium and the blood compartment are perturbed.

A Novel In vitro Model for Studying the Interactions Between Human Whole Blood and Endothelium

The accessibility of reliable models to investigate vascular blood interactions in humans is lacking. We present an in vitro model of cultured primary human endothelial cells combined with human whole blood to investigate cellular interactions both in the blood (ELISA) and the vascular compartment (microscopy).

Роман<em&gt; В пробирке</em&gt; Модель для изучения взаимодействия между человеческим цельной крови и эндотелия

The majority of all known diseases are accompanied by disorders of the cardiovascular system. Studies into the complexity of the interacting pathways ...

In Vitro Analysis of Myd88-mediated Cellular Immune Response to West Nile Virus Mutant Strain Infection

An attenuated West Nile virus (WNV), a nonstructural (NS) 4B-P38G mutant, induced higher innate cytokine and T cell responses than the wild-type WNV in mice. Recently, myeloid differentiation factor 88 (MyD88) signaling was shown to be important for initial T cell priming and memory T cell development during WNV NS4B-P38G mutant infection. In this study, two flow cytometry-based methods &#8211; an in vitro T cell priming assay and an intracellular cytokine staining (ICS) &#8211; were utilized to assess dendritic cells (DCs) and T cell functions. In the T cell priming assay, cell proliferation was analyzed by flow cytometry following co-culture of DCs from both groups of mice with carboxyfluorescein succinimidyl ester (CFSE) - labeled CD4+ T cells of OTII transgenic mice. This approach provided an accurate determination of the percentage of proliferating CD4+ T cells with significantly improved overall sensitivity than the traditional assays with radioactive reagents. A microcentrifuge tube system was used in both cell culture and cytokine staining procedures of the ICS protocol. Compared to the traditional tissue culture plate-based system, this modified procedure was easier to perform at biosafety level (BL) 3 facilities. Moreover, WNV- infected cells were treated with paraformaldehyde in both assays, which enabled further analysis outside BL3 facilities. Overall, these in vitro immunological assays can be used to efficiently assess cell-mediated immune responses during WNV infection.

In Vitro Analysis of Myd88-mediated Cellular Immune Response to West Nile Virus Mutant Strain Infection

Two flow cytometry-based methods &#8211; an in vitro T cell priming assay and intracellular cytokine staining were utilized to measure antigen presenting capacity of dendritic cells and antigen-specific T cell responses to a West Nile virus mutant infection in mice.

In Vitro анализ MyD88-опосредованной клеточного иммунного ответа на вирус Западного Нила мутантный штамм инфекции

An attenuated West Nile virus (WNV), a nonstructural (NS) 4B-P38G mutant, induced higher innate cytokine and T cell responses than the wild-type WNV in ...

An In Vitro Model for Measuring Immune Responses to Malaria in the Context of HIV Co-infection

Malaria and HIV co-infection is a growing health priority. However, most research on malaria or HIV currently focuses on each infection individually. Although understanding the disease dynamics for each of these pathogens independently is vital, it is also important that the interactions between these pathogens are investigated and understood. 
We have developed a versatile in vitro model of HIV-malaria co-infection to study host immune responses to malaria in the context of HIV infection. Our model allows the study of secreted factors in cellular supernatants, cell surface and intracellular protein markers, as well as RNA expression levels. The experimental design and methods used limit variability and promote data reliability and reproducibility. 
All pathogens used in this model are natural human pathogens (Plasmodium falciparum and HIV-1), and all infected cells are naturally infected and used fresh. We use human erythrocytes parasitized with P. falciparum and maintained in continuous in vitro culture. We obtain freshly isolated peripheral blood mononuclear cells from chronically HIV-infected volunteers. Every condition used has an appropriate control (P. falciparum parasitized vs. normal erythrocytes), and every HIV-infected donor has an HIV uninfected control, from which cells are harvested on the same day. This model provides a realistic environment to study the interactions between malaria parasites and human immune cells in the context of HIV infection.

An In Vitro Model for Measuring Immune Responses to Malaria in the Context of HIV Co-infection

Human co-infection is difficult to replicate in vitro. However, human malaria parasites can readily be cultured in vitro, as can freshly isolated human peripheral blood mononuclear cells naturally infected with HIV. This provides an excellent model for studying early immune responses to malaria parasites in the context of HIV co-infection.

<em&gt; In Vitro</em&gt; Модель для измерения иммунных ответов на малярией в контексте ВИЧ-инфекцией

Malaria and HIV co-infection is a growing health priority. However, most research on malaria or HIV currently focuses on each infection individually. ...

Studying Microbial Communities In Vivo: A Model of Host-mediated Interaction Between Candida Albicans and Pseudomonas Aeruginosa in the Airways

Studying host-pathogen interaction enables us to understand the underlying mechanisms of the pathogenicity during microbial infection. The prognosis of the host depends on the involvement of an adapted immune response against the pathogen1. Immune response is complex and results from interaction of the pathogens and several immune or non-immune cellular types2. In vitro studies cannot characterise these interactions and focus on cell-pathogen interactions. Moreover, in the airway3, particularly in patients with suppurative chronic lung disease or in mechanically ventilated patients, polymicrobial communities are present and complicate host-pathogen interaction. Pseudomonas aeruginosa and Candida albicans are both problem pathogens4, frequently isolated from tracheobronchial samples, and associated to severe infections, especially in intensive care unit5. Microbial interactions have been reported between these pathogens in vitro but the clinical impact of these interactions remains unclear6. To study the interactions between C. albicans and P. aeruginosa, a murine model of C. albicans airways colonization, followed by a P. aeruginosa-mediated acute lung infection was performed.

Studying Microbial Communities In Vivo: A Model of Host-mediated Interaction Between Candida Albicans and Pseudomonas Aeruginosa in the Airways

While in vitro study of host-pathogen interactions allow the characterization of specific immune responses, in vivo models are required to observe the effects of complex responses. Using Candida albicans exposure followed by Pseudomonas aeruginosa-mediated lung infection, we established a murine model of microbial interactions involved in ventilator-associated pneumonia pathogenicity.

Изучение микробных сообществ<em&gt; В Vivo</em&gt;: Модель узла опосредованного взаимодействия между<em&gt; Candida Albicans</em&gt; И<em&gt; Синегнойной палочки</em&gt; В Airways

Studying host-pathogen interaction enables us to understand the underlying mechanisms of the pathogenicity during microbial infection. The prognosis of ...

An In Vitro Model of the Blood-brain Barrier Using Impedance Spectroscopy: A Focus on T Cell-endothelial Cell Interaction

Breakdown of the blood-brain barrier (BBB) is a critical step in the development of autoimmune diseases such as multiple sclerosis (MS) and its animal model experimental autoimmune encephalomyelitis (EAE). This process is characterized by the transmigration of activated T cells across brain endothelial cells (ECs), the main constituents of the BBB. However, the consequences on brain EC function upon interaction with such T cells are largely unknown. Here we describe an assay that allows for the evaluation of primary mouse brain microvascular EC (MBMEC) function and barrier integrity during the interaction with T cells over time. The assay makes use of impedance cell spectroscopy, a powerful tool for studying EC monolayer integrity and permeability, by measuring changes in transendothelial electrical resistance (TEER) and cell layer capacitance (Ccl). In direct contact with ECs, stimulated but not na&#239;ve T cells are capable of inducing EC monolayer dysfunction, as visualized by a decrease in TEER and an increase in Ccl. The assay records changes in EC monolayer integrity in a continuous and automated fashion. It is sensitive enough to distinguish between different strengths of stimuli and levels of T cell activation and it enables the investigation of the consequences of a targeted modulation of T cell-EC interaction using a wide range of substances such as antibodies, pharmacological reagents and cytokines. The technique can also be used as a quality control for EC integrity in in vitro T-cell transmigration assays. These applications make it a versatile tool for studying BBB properties under physiological and pathophysiological conditions.

An In Vitro Model of the Blood-brain Barrier Using Impedance Spectroscopy: A Focus on T Cell-endothelial Cell Interaction

Here, we describe an in vitro murine model of the blood-brain barrier that makes use of impedance cell spectroscopy, with a focus on the consequences on endothelial cell integrity and permeability upon interaction with activated T cells.

<em&gt; In Vitro</em&gt; Модель гематоэнцефалического барьера Использование импедансной спектроскопии: основноевнимание- Т-клеток-эндотелиальной клеточное взаимодействие

Breakdown of the blood-brain barrier (BBB) is a critical step in the development of autoimmune diseases such as multiple sclerosis (MS) and its animal ...

Visualizing the Effects of Sputum on Biofilm Development Using a Chambered Coverglass Model

Biofilms consist of groups of bacteria encased in a self-secreted matrix. They play an important role in industrial contamination as well as in the development and persistence of many health related infections. One of the most well described and studied biofilms in human disease occurs in chronic pulmonary infection of cystic fibrosis patients. When studying biofilms in the context of the host, many factors can impact biofilm formation and development. In order to identify how host factors may affect biofilm formation and development, we used a static chambered coverglass method to grow biofilms in the presence of host-derived factors in the form of sputum supernatants. Bacteria are seeded into chambers and exposed to sputum filtrates. Following 48 hr of growth, biofilms are stained with a commercial biofilm viability kit prior to confocal microscopy and analysis. Following image acquisition, biofilm properties can be assessed using different software platforms. This method allows us to visualize key properties of biofilm growth in presence of different substances including antibiotics.

This protocol describes the visualization of biofilm development following exposure to host-factors using a slide chamber model. This model allows for direct visualization of biofilm development as well as analysis of biofilm parameters using computer software programs.

Визуализация Эффекты мокроте на биопленки развития с использованием модели Chambered покровного стекла

Biofilms consist of groups of bacteria encased in a self-secreted matrix. They play an important role in industrial contamination as well as in the ...

Development of an Economical DNA Delivery System by "Acufection" and its Application to Skin Research

Dysregulation of immune response in skin is associated with numerous human skin disorders. Direct transfer of immune-related genes into skin tissue is a fascinating approach to investigate immune modulation of cutaneous inflammation in mouse models of human diseases. Here we present a cost-effective protocol that delivered naked DNA in mouse skin and leads to transgene expression. The method is coined &#34;acufection&#34;, denoting acupuncture-mediated DNA transfection. To perform acufection, mouse skin was first infused with DNA in phosphate-buffered saline (PBS) and then pricked lightly with a bundle of acupuncture needles to facilitate the absorption of DNA and transfection into cells. The plasmid DNA is presumably taken up by the keratinocyte and dendritic cells (DCs) in the skin and expressed into protein. Mechanical prick with the needles per se did not cause skin damage or induce keratinocyte activation. The expression of the transfected genes was detected in the skin at both transcriptional and translational levels following acufection for 2 days and maintained up to 7 days. The primary goal for the development of this acufection method was to investigate a previously undefined isoform of IL-15. Using this method, an alternatively spliced IL-15 isoform with partially deleted exon 7 (IL-15&#916;E7) was expressed in the skin and subsequently treated with a Toll-like receptor 7 (TLR7) agonist, imiquimod (IMQ), to induce inflammation. Acufection-delivered IL-15&#916;E7 in skin suppressed keratinocyte proliferation, epidermal thickness and neutrophil recruitment in IMQ-induced cutaneous inflammation. With increasing interest in identifying the regulatory mechanisms of cutaneous inflammation, the protocol described here provides a cost effective and versatile alternative to the gene gun system or microseeding for DNA delivery in vivo. It may potentially allow discovery of the function of a novel gene in the skin or for investigating new treatment for cutaneous diseases.

Development of an Economical DNA Delivery System by &quot;Acufection&quot; and its Application to Skin Research

This protocol is a cost-effective alternative for expressing naked plasmid DNA in mouse skin. The overall goal of the protocol is to deliver immune-related genes into skin tissue to delineate the functional role of a specific gene in cutaneous inflammation.

Разработка системы доставки Экономичный ДНК по «Acufection» и его применение к исследованию кожи

Dysregulation of immune response in skin is associated with numerous human skin disorders. Direct transfer of immune-related genes into skin tissue is a ...